Researchers determined the link between improved access to sanitation and better water quality and the human intestines’ antibiotic resistance gene frequency.
Filament Health Announces FDA Opening of Investigational New Drug Application for Substance Use Disorders | Psychedelic Invest
VANCOUVER, BC, Jan. 31, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company, today